Is Growth Hormone a Radioprotective Agent?
February 2006
in “
Journal of the European Academy of Dermatology and Venereology
”
Studysummary This study found that growth hormone significantly reduced radiation-induced skin damage in rats compared to radiation alone, suggesting potential for mitigating such effects in cancer patients.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study investigated the potential of growth hormone (GH) as a radioprotective agent using a radiation-induced skin injury model in rats. Rats were divided into four groups: a control group, a radiation group receiving 30 Gy of gamma irradiation, and two groups receiving the same irradiation plus either 0.01 U/kg/day or 0.02 U/kg/day GH. Results showed that GH significantly reduced the severity of radiodermatitis compared to the radiation-only group, delaying its onset and preventing epidermal atrophy, dermal degeneration, and hair follicle atrophy. These findings suggested that GH could mitigate radiation-induced skin damage, warranting further studies with higher GH doses in cancer patients undergoing radiation therapy.
